Membrane TNF Confers Protection to Acute Mycobacterial Infection

Overview

Journal Respir Res

Specialty Pulmonary Medicine

Date 2005 Nov 16

PMID 16285886

Citations 28

Authors

Cecile Fremond

Nasiema Allie

Ivy Dambuza

Sergei I Grivennikov

Vladimir Yeremeev

Valerie F J Quesniaux

Muazzam Jacobs

Bernhard Ryffel

Affiliations

Soon will be listed here.

Abstract

Background: Tumour necrosis factor (TNF) is crucial for the control of mycobacterial infection as TNF deficient (KO) die rapidly of uncontrolled infection with necrotic pneumonia. Here we investigated the role of membrane TNF for host resistance in knock-in mice with a non-cleavable and regulated allele (mem-TNF).

Methods: C57BL/6, TNF KO and mem-TNF mice were infected with M. tuberculosis H37Rv (Mtb at 100 CFU by intranasal administration) and the survival, bacterial load, lung pathology and immunological parameters were investigated. Bone marrow and lymphocytes transfers were used to test the role of membrane TNF to confer resistance to TNF KO mice.

Results: While TNF-KO mice succumbed to infection within 4-5 weeks, mem-TNF mice recruited normally T cells and macrophages, developed mature granuloma in the lung and controlled acute Mtb infection. However, during the chronic phase of infection mem-TNF mice succumbed to disseminated infection with necrotic pneumonia at about 150 days. Reconstitution of irradiated TNF-KO mice with mem-TNF derived bone marrow cells, but not with lymphocytes, conferred host resistance to Mtb infection in TNF-KO mice.

Conclusion: Membrane expressed TNF is sufficient to allow cell-cell signalling and control of acute Mtb infection. Bone marrow cells, but not lymphocytes from mem-TNF mice confer resistance to infection in TNF-KO mice. Long-term infection control with chronic inflammation likely disrupting TNF mediated cell-cell signalling, additionally requires soluble TNF.

Citing Articles

Tumor necrosis factor regulates leukocyte recruitment but not bacterial persistence during Staphylococcus aureus craniotomy infection.

Van Roy Z, Kielian T J Neuroinflammation. 2024; 21(1):179.

PMID: 39044282 PMC: 11264501. DOI: 10.1186/s12974-024-03174-9.

Congenital iRHOM2 deficiency causes ADAM17 dysfunction and environmentally directed immunodysregulatory disease.

Kubo S, Fritz J, Raquer-McKay H, Kataria R, Vujkovic-Cvijin I, Al-Shaibi A Nat Immunol. 2021; 23(1):75-85.

PMID: 34937930 PMC: 11060421. DOI: 10.1038/s41590-021-01093-y.

Interleukin-13-Overexpressing Mice Represent an Advanced Preclinical Model for Detecting the Distribution of Antimycobacterial Drugs within Centrally Necrotizing Granulomas.

Walter K, Kokesch-Himmelreich J, Treu A, Waldow F, Hillemann D, Jakobs N Antimicrob Agents Chemother. 2021; 66(6):e0158821.

PMID: 34871095 PMC: 9211424. DOI: 10.1128/AAC.01588-21.

Susceptibility to Intracellular Infections: Contributions of TNF to Immune Defense.

Li X, Korner H, Liu X Front Microbiol. 2020; 11:1643.

PMID: 32760383 PMC: 7374010. DOI: 10.3389/fmicb.2020.01643.

Differential Interactions of Serum and Bronchoalveolar Lavage Fluid Complement Proteins with Conidia of Airborne Fungal Pathogen Aspergillus fumigatus.

Wong S, Daniel I, Gangneux J, Jayapal J, Guegan H, Delliere S Infect Immun. 2020; 88(9).

PMID: 32571987 PMC: 7440762. DOI: 10.1128/IAI.00212-20.

References

Cooper A, Roberts A, RHOADES E, Callahan J, Getzy D, Orme I . The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology. 1995; 84(3):423-32. PMC: 1415123. View

MacMicking J, Nathan C, Hom G, Chartrain N, Fletcher D, Trumbauer M . Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 1995; 81(4):641-50. DOI: 10.1016/0092-8674(95)90085-3. View

Flynn J, GOLDSTEIN M, Chan J, Triebold K, Pfeffer K, Lowenstein C . Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 1995; 2(6):561-72. DOI: 10.1016/1074-7613(95)90001-2. View

Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B . The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 1995; 83(5):793-802. DOI: 10.1016/0092-8674(95)90192-2. View

Muller M, Eugster H, Le Hir M, Shakhov A, Di Padova F, Maurer C . Correction or transfer of immunodeficiency due to TNF-LT alpha deletion by bone marrow transplantation. Mol Med. 1996; 2(2):247-55. PMC: 2230110. View

Akassoglou K, Probert L, Kontogeorgos G, Kollias G . Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol. 1997; 158(1):438-45. View

Black R, Rauch C, Kozlosky C, Peschon J, Slack J, Wolfson M . A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997; 385(6618):729-33. DOI: 10.1038/385729a0. View

Cooper A, Magram J, Ferrante J, Orme I . Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J Exp Med. 1997; 186(1):39-45. PMC: 2198958. DOI: 10.1084/jem.186.1.39. View

Marino M, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E . Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A. 1997; 94(15):8093-8. PMC: 21562. DOI: 10.1073/pnas.94.15.8093. View

10.

Lucas R, Juillard P, Decoster E, Redard M, Burger D, Donati Y . Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol. 1997; 27(7):1719-25. DOI: 10.1002/eji.1830270719. View

11.

Kusters S, Tiegs G, Alexopoulou L, Pasparakis M, Douni E, Kunstle G . In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur J Immunol. 1997; 27(11):2870-5. DOI: 10.1002/eji.1830271119. View

12.

Marino M, Horton M, Jungbluth A, Burdick M, Strieter R, Noble P . Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc Natl Acad Sci U S A. 1998; 95(23):13806-11. PMC: 24904. DOI: 10.1073/pnas.95.23.13806. View

13.

Lutz M, Kukutsch N, OGILVIE A, Rossner S, Koch F, Romani N . An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999; 223(1):77-92. DOI: 10.1016/s0022-1759(98)00204-x. View

14.

Bean A, Roach D, Briscoe H, France M, Korner H, Sedgwick J . Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol. 1999; 162(6):3504-11. View

15.

Fremond C, Yeremeev V, Nicolle D, Jacobs M, Quesniaux V, Ryffel B . Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J Clin Invest. 2004; 114(12):1790-9. PMC: 535064. DOI: 10.1172/JCI21027. View

16.

Grivennikov S, Tumanov A, Liepinsh D, Kruglov A, Marakusha B, Shakhov A . Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. Immunity. 2005; 22(1):93-104. DOI: 10.1016/j.immuni.2004.11.016. View

17.

Olleros M, Guler R, Vesin D, Parapanov R, Marchal G, Martinez-Soria E . Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections. Am J Pathol. 2005; 166(4):1109-20. PMC: 1602380. DOI: 10.1016/S0002-9440(10)62331-0. View

18.

Saunders B, Tran S, Ruuls S, Sedgwick J, Briscoe H, Britton W . Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection. J Immunol. 2005; 174(8):4852-9. DOI: 10.4049/jimmunol.174.8.4852. View

19.

Keane J . TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. Rheumatology (Oxford). 2005; 44(6):714-20. DOI: 10.1093/rheumatology/keh567. View

20.

Flynn J, Chan J, Triebold K, Dalton D, Stewart T, Bloom B . An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993; 178(6):2249-54. PMC: 2191274. DOI: 10.1084/jem.178.6.2249. View